#Canada #Toronto #Alzheimer's Disease #Tau Tangle #eMTBR-Tau

Upcoming Xtalks Webinar: Advances in Tau Tangle Detection

Xtalks will host a free and informative webinar that focuses on the groundbreaking implications of measuring plasma eMTBR-Tau, an emerging biomarker linked to tau tangle pathology in Alzheimer's disease. The session will be led by leading experts who will provide insights into how this novel blood-based marker stands apart from traditional phosphorylated tau biomarkers, unveiling its potential impact on our understanding of Alzheimer's disease.

Understanding Alzheimer's Disease and the Role of Biomarkers

Alzheimer's disease is a complex neurodegenerative disorder characterized by the accumulation of tau tangles and amyloid plaques in the brain. As the disease progresses, various pathological processes unfold, highlighting the critical need for biomarkers that can capture the multifaceted nature of the disease. Current plasma biomarkers like phosphorylated tau (pTau) have shown strong correlations with amyloid pathology, yet they fall short of representing the full spectrum of Alzheimer's disease biology.

With the advent of eMTBR-Tau, researchers now have a promising new tool to investigate the intricate dynamics of tau tangle formation. This endogenous microtubule-binding region of tau is found in the filament cores that form neurofibrillary tangles, allowing for enhanced monitoring of tau aggregates and their relation to disease progression.

Webinar Highlights

Speaker Insights

The webinar will feature Dr. Tracy Liu from Spear Bio and Dr. Thomas Karikari from the University of Pittsburgh. They will discuss key topics such as:

• - The methodologies enabling ultrasensitive detection of eMTBR-Tau in plasma samples.
• - The differences between eMTBR-Tau and previously established tau biomarkers.
• - How eMTBR-Tau reflects various stages of tau pathology through the disease continuum.

Methodological Advancements

One major topic for discussion will be the innovative analytical techniques used to measure low-abundance biomarkers like eMTBR-Tau. Attendees will gain insights into a cutting-edge immunoassay approach that facilitates the detection of these proteins from minuscule sample volumes (as little as 1 µL), making it feasible to monitor tau pathology in real-world applications.

Biological Insights

The webinar will delve into how eMTBR-Tau contributes to understanding the transition from early amyloid-associated tau modifications to more severe tau tangle pathology. By reviewing data from amyloid- and tau-PET characterized research cohorts, participants will learn about eMTBR-Tau's potential role in advancing our knowledge of Alzheimer’s disease.

Register for the Webinar

Don't miss out on this opportunity to enhance your understanding of tau tangle pathology and the promising role of eMTBR-Tau in Alzheimer's research. Join us on October 2, 2026, at 11 AM EDT for this live discussion. To register, visit Xtalks Webinar. Your participation could significantly contribute to the ongoing dialogue around Alzheimer's disease and its biomarkers.

About Xtalks

Xtalks is a community dedicated to advancing the life sciences sector by providing professionals with reliable information and insights. Through webinars, articles, and collaborative exchanges, Xtalks empowers stakeholders in pharma, biotech, medtech, and healthcare to make informed decisions and collaboratively navigate the evolving landscape of health science.

For further details regarding the event or potential collaboration opportunities, please contact Soumya Shashikumar at +1 (416) 977-6555 x371 or via email at [email protected].